IFA

Invus Financial Advisors Portfolio holdings

AUM $89.2M Turnover 0%
1-Year Est. Return 10.79%
This Fund
S&P 500
This Quarter Est. Return
-27.35%
1 Year Est. Return
-10.79%
3 Year Est. Return
-29.46%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$225M
AUM Growth
-$104M
Cap. Flow
-$3.76M
Cap. Flow %
-1.67%
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
–
Reduced
1
Closed
1
Avg Time Held
1.3 years
Top 10 Avg Time Held
1.3 years
Top 20 Avg Time Held
1.3 years

Top Buys

Rank Stock Value
1
DIDI
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
+$359K

Top Sells

Rank Stock Value
1
CPNG icon
Coupang
CPNG
+$2.52M
2
UBX icon
Unity Biotechnology
UBX
+$1.6M

Sector Composition

Rank Sector Weight
1 Healthcare 52.3%
2 Consumer Discretionary 23.97%
3 Communication Services 17.95%
4 Technology 5.68%
5 Industrials 0.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CPNG icon
1
Coupang
CPNG
$25.8B
$53.9M 23.97%
3,046,571
-118,000
-4% -$2.52M
2021 Q1
4 quarters
RCUS icon
2
Arcus Biosciences
RCUS
$2.89B
$50.9M 22.64%
1,612,077
– –
2019 Q4
9 quarters
TBLA icon
3
Taboola.com
TBLA
$919M
$40.4M 17.95%
7,819,690
– –
2021 Q2
3 quarters
OYST
4
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$32.2M 14.34%
2,768,586
– –
2019 Q4
9 quarters
NVCR icon
5
NovoCure
NVCR
$1.62B
$29.1M 12.93%
350,884
– –
2019 Q4
9 quarters
IONQ icon
6
IonQ
IONQ
$12.8B
$12.8M 5.68%
1,000,000
– –
2021 Q4
1 quarter
ORIC icon
7
Oric Pharmaceuticals
ORIC
$1.2B
$5.38M 2.39%
1,007,575
– –
2020 Q2
7 quarters
DIDI
8
DELISTED
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
$228K 0.1%
+91,085
New +$359K
2022 Q1
0 quarters
UBX icon
9
DELISTED
Unity Biotechnology
UBX
– –
-109,500
Closed -$1.6M –

Similar funds

ETIA
Epic Trust Investment Advisors Richland, Washington $90.8M AUM 22.03% 1-Year Est. Return
CC
Cowbird Capital New York $87M AUM 10.91% 1-Year Est. Return
OAMA
Oslo Asset Management AS Oslo, Norway $86.5M AUM 12.57% 1-Year Est. Return
FWM
FMFE Wealth Management Syracuse, New York $108M AUM
GIM
Greenwich Investment Management Norwalk, Connecticut $109M AUM 9.72% 1-Year Est. Return
YSP
Yarra Square Partners New York $111M AUM 41.61% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Invus Financial Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Invus Financial Advisors held 9 positions worth $225M, down 32% from $329M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Invus Financial Advisors's Q1 2022 filing shows 1 new, 1 reduced and 1 closed positions. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 91,085 shares worth $228K. The largest sale was Coupang, an estimated $2.52M.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 48% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Invus Financial Advisors's largest Q1 2022 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 91,085 shares worth $228K.
  • Invus Financial Advisors's biggest Q1 2022 reduction was Coupang, cutting an estimated $2.52M.
  • Invus Financial Advisors fully exited Unity Biotechnology in Q1 2022, selling an estimated $1.6M.
  • Invus Financial Advisors's ten largest holdings make up 100% of its $225M portfolio in Q1 2022.
  • Invus Financial Advisors opened 1 new position and closed 1 in Q1 2022.
  • Invus Financial Advisors's portfolio value fell 32% quarter-over-quarter to $225M.

Based on Invus Financial Advisors's 13F filing for Q1 2022, filed 16 May 2022.